Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Articles|October 1, 2004
- Volume 0 0
Test Identifies Ovarian Cancer
Advertisement
John Hopkins researchers have developeda test to detect ovarian cancer byidentifying 3 proteins found in the bloodof women with the disease, according toan article reported in Cancer Research(August 15, 2004). Earlier studies withthe test suggested that there is a molecularsignature exclusive to ovarian cancer,which can remain undetected andspread quickly.
"By identifying a select group of biomarkersspecific to ovarian cancer, we notonly know the proteins we are dealingwith, but we can trace them back to alterationsin the genetic code of ovarian cancercells," said Daniel W. Chan, PhD,director of Biomarker Discovery Center atJohns Hopkins.
Additional studies are needed, however,before the test is commercially availablefor screening ovarian cancer. Chanpointed out that no blood test will be ableto correctly diagnose 100% of canceroustumors all the time.
Articles in this issue
about 22 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationabout 22 years ago
System Improves Productivity, Drug Verificationabout 22 years ago
COMPOUNDING HOTLINEabout 22 years ago
Cardinal Introduces PatientPAK 340Babout 22 years ago
Obesity Is an Addiction, Researchers Sayabout 22 years ago
Scientists Seek to Understand How Fat Causes Cancerabout 22 years ago
Government Plans Attack on Obesityabout 22 years ago
Gene Discovery May Unlock Key to Obesity Syndromeabout 22 years ago
Consuming Fruit, Not Fat, Staves Off Weight GainAdvertisement
Related to this article
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
2
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
3
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
4
Lilly–Hims & Hers GLP-1 Deal Tests Whether Convenience Can Deliver Continuity of Care
5